Thomas R. Sciascia
Net Worth

Last updated:

What is Thomas R. Sciascia net worth?

The estimated net worth of Dr. Thomas R. Sciascia is at least $2,363,353 as of 19 Aug 2024. He owns shares worth $1,614,909 as insider, has earned $272,194 from insider trading and has received compensation worth at least $476,250 in Trevi Therapeutics, Inc..

What is the salary of Thomas R. Sciascia?

Dr. Thomas R. Sciascia salary is $476,250 per year as Co-Founder & Chief Medical Officer in Trevi Therapeutics, Inc..

How old is Thomas R. Sciascia?

Dr. Thomas R. Sciascia is 72 years old, born in 1953.

What stocks does Thomas R. Sciascia currently own?

As insider, Dr. Thomas R. Sciascia owns shares in one company:

Company Title Shares Price per share Total value
Trevi Therapeutics, Inc. (TRVI) Co-Founder & Chief Medical Officer 220,315 $7.33 $1,614,909

What does Trevi Therapeutics, Inc. do?

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

TRVI logo
TRVI
Trevi Therapeutics, Inc.
$7.33

Thomas R. Sciascia insider trading

Trevi Therapeutics, Inc.

Dr. Thomas R. Sciascia has made 5 insider trades in 2024, according to the Form 4 filled with the SEC. Most recently he sold 16,496 units of TRVI stock worth $48,878 on 19 Aug 2024.

The largest trade he's ever made was exercising 59,354 units of TRVI stock on 29 May 2024. As of 19 Aug 2024 he still owns at least 220,315 units of TRVI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 16,496 $2.96 $48,878
Option
Stock Option (right to buy) 16,496 $1.43 $23,589
Option
Common Stock 16,496 $1.43 $23,589
Option
Stock Option (right to buy) 18,660 $1.43 $26,684
Option
Common Stock 18,660 $1.43 $26,684
Sale
Common Stock 18,660 $2.76 $51,446
Option
Stock Option (right to buy) 12,745 $1.43 $18,225
Option
Common Stock 12,745 $1.43 $18,225
Sale
Common Stock 12,745 $2.79 $35,508
Sale
Common Stock 100 $2.75 $275
Option
Stock Option (right to buy) 100 $1.43 $143
Option
Common Stock 100 $1.43 $143
Option
Common Stock 59,354 $2.19 $129,985
Sale
Common Stock 53,368 $2.55 $136,088
Option
Stock Option (right to buy) 59,354 $2.19 $129,985

Trevi Therapeutics key executives

Trevi Therapeutics, Inc. executives and other stock owners filed with the SEC: